CHEWABLE ASPIRIN

N/A

Manufactured by Chain Drug Marketing Association, Inc.

121 FDA adverse event reports analyzed

Last updated: 2026-04-14

About CHEWABLE ASPIRIN

CHEWABLE ASPIRIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chain Drug Marketing Association, Inc.. The most commonly reported adverse reactions for CHEWABLE ASPIRIN include DRUG INEFFECTIVE, CHEST PAIN, FLUSHING, NAUSEA, ABDOMINAL PAIN UPPER. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHEWABLE ASPIRIN.

Top Adverse Reactions

DRUG INEFFECTIVE4 reports
CHEST PAIN3 reports
FLUSHING3 reports
NAUSEA3 reports
ABDOMINAL PAIN UPPER2 reports
BURNING SENSATION2 reports
CARDIAC DISORDER2 reports
DECREASED APPETITE2 reports
DIARRHOEA2 reports
DYSPNOEA2 reports
ERYTHEMA2 reports
HAIR TEXTURE ABNORMAL2 reports
HALLUCINATION2 reports
INTENTIONAL PRODUCT MISUSE2 reports
PAIN2 reports
PRURITUS2 reports
ADVERSE DRUG REACTION1 reports
ALOPECIA1 reports
ANAPHYLACTIC SHOCK1 reports
ANXIETY1 reports
APPLICATION SITE PAIN1 reports
ARTERIAL OCCLUSIVE DISEASE1 reports
ATROPHY1 reports
BLEPHAROSPASM1 reports
BLOOD CREATININE INCREASED1 reports
BLOOD POTASSIUM DECREASED1 reports
BODY HEIGHT DECREASED1 reports
BURKHOLDERIA TEST POSITIVE1 reports
CARDIAC ARREST1 reports
CARDIAC FAILURE1 reports
CEREBROVASCULAR ACCIDENT1 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE1 reports
COLON CANCER1 reports
CONSTIPATION1 reports
CONTRAST MEDIA REACTION1 reports
CONTUSION1 reports
DEATH1 reports
DEHYDRATION1 reports
DIABETIC KETOACIDOSIS1 reports
DIARRHOEA HAEMORRHAGIC1 reports
DISCOMFORT1 reports
DISEASE RECURRENCE1 reports
DIZZINESS1 reports
DRUG EFFECT INCOMPLETE1 reports
DRY SKIN1 reports
DYSGEUSIA1 reports
ENTEROCOCCUS TEST POSITIVE1 reports
EOSINOPHIL COUNT INCREASED1 reports
EYE PAIN1 reports
FATIGUE1 reports
FEELING ABNORMAL1 reports
FEELING HOT1 reports
FORMICATION1 reports
GASTROOESOPHAGEAL REFLUX DISEASE1 reports
HAIR COLOUR CHANGES1 reports
HAIR DISORDER1 reports
HEADACHE1 reports
HYPERSENSITIVITY1 reports
HYPOACUSIS1 reports
HYPOTENSION1 reports
HYPOXIA1 reports
IMPAIRED WORK ABILITY1 reports
INCORRECT DOSE ADMINISTERED1 reports
INJECTION SITE EXTRAVASATION1 reports
INJECTION SITE PAIN1 reports
INSOMNIA1 reports
LIP DRY1 reports
MADAROSIS1 reports
MALAISE1 reports
MICTURITION URGENCY1 reports
MIGRAINE WITH AURA1 reports
MUSCLE SPASMS1 reports
MYALGIA1 reports
MYOCARDIAL INFARCTION1 reports
OFF LABEL USE1 reports
OROPHARYNGEAL PAIN1 reports
OXYGEN SATURATION DECREASED1 reports
PARAESTHESIA1 reports
PERIPHERAL MOTOR NEUROPATHY1 reports
PNEUMONIA1 reports
POOR PERIPHERAL CIRCULATION1 reports
PRODUCT DISPENSING ERROR1 reports
PRODUCT PHYSICAL CONSISTENCY ISSUE1 reports
PRODUCT QUALITY ISSUE1 reports
PRODUCT TAMPERING1 reports
PRODUCT TASTE ABNORMAL1 reports
PYREXIA1 reports
RECALLED PRODUCT ADMINISTERED1 reports
RECTAL HAEMORRHAGE1 reports
SCAB1 reports
SINUS DISORDER1 reports
SKIN BURNING SENSATION1 reports
SKIN DISORDER1 reports
SKIN EXFOLIATION1 reports
SLEEP APNOEA SYNDROME1 reports
SLEEP DISORDER1 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION1 reports
STENT PLACEMENT1 reports
STRESS1 reports
SUPRAVENTRICULAR EXTRASYSTOLES1 reports

Report Outcomes

Out of 33 classified reports for CHEWABLE ASPIRIN:

Serious 57.6%Non-Serious 42.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male19 (57.6%)
Female14 (42.4%)

Reports by Age

Age 443 reports
Age 592 reports
Age 622 reports
Age 732 reports
Age 361 reports
Age 401 reports
Age 601 reports
Age 611 reports
Age 631 reports
Age 641 reports
Age 651 reports
Age 661 reports
Age 691 reports
Age 721 reports
Age 741 reports
Age 751 reports
Age 781 reports
Age 6721 reports
Age 197261 reports
Age 274721 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CHEWABLE ASPIRIN?

This profile reflects 121 FDA FAERS reports that mention CHEWABLE ASPIRIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CHEWABLE ASPIRIN?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, CHEST PAIN, FLUSHING, NAUSEA, ABDOMINAL PAIN UPPER, BURNING SENSATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CHEWABLE ASPIRIN?

Labeling and FAERS entries often list Chain Drug Marketing Association, Inc. in connection with CHEWABLE ASPIRIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.